Rapport Therapeutics, Inc. · NASDAQ:RAPP
Yeleswaram Krishnaswamy sold 404 Rapport Therapeutics, Inc. shares (Form 4)
Traded Aug 19, 2026 · Filed Aug 20, 2026
On Aug 19, 2026, Yeleswaram Krishnaswamy (Chief Development Officer) sold 404 Rapport Therapeutics, Inc. shares at US$49.90 for US$20,160 under a trading plan, leaving 246,022 shares. Filed Aug 20, 2026 (Form 4).
- Sold
- 404 shares
- Price
- US$49.90
- Value
- US$20,160
- Holding after
- 246,022 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Common Stock | Sale | 404 | US$49.90 | 246,022 | Direct |
Source
Related
- Rapport Therapeutics, Inc.
- Yeleswaram Krishnaswamy
- Rapport Therapeutics, Inc. shareholders
- Form 4 · Yeleswaram Krishnaswamy · Aug 26, 2026
- Form 4 · Yeleswaram Krishnaswamy · Apr 21, 2026
- Form 4 · Yeleswaram Krishnaswamy · Apr 14, 2026
- Form 4 · Yeleswaram Krishnaswamy · Apr 9, 2026
- Form 4 · Ignelzi Troy A. · Oct 21, 2026
- Form 4 · Ceesay Abraham · Oct 8, 2026
- Form 4 · Gault Cheryl · Oct 1, 2026
- Form 4 · Ceesay Abraham · Sep 24, 2026
- Form 4 · Ceesay Abraham · Sep 9, 2026